Company: FEAV
Filing Date: 2025-08-25
Form Type: 424B5
Source: 0001888654-25-000019
Chunk: 20

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-08-25
Form: 424B5
Chunk 20
---
----|-------------:|
| Public offering price                   |     | $            |     |  3.50 |     | $     |     | 8,310,683.50 |
| Underwriting discount and commission(2) |     | $            |     | 0.245 |     | $     |     |   581,747.84 |
| Proceeds to us, before expenses         |     | $            |     | 3.255 |     | $     |     | 7,728,935.66 |

__________________ (1) The public offering price and underwriting discount corresponds to a public offering price per share of common stock of $3.50 ($3.255 net of the underwriting discount). (2) We have also agreed to reimburse the representative at closing for legal expenses incurred by it in connection with the offering up to $120,000. We estimate that our total offering expenses for this offering, net of the underwriting discount and commission, will be approximately $0.4 million. Listing Our shares of common stock are listed on Nasdaq under the symbol “FEAM.” Our CDIs are listed on the Australian Securities Exchange under the symbol “5EA” with ten CDIs representing an interest in one share of our common stock. The last reported sales price of our shares of common stock on August 21, 2025, was $4.57 per share. The actual public offering price was determined between us, the underwriter and the investors in the offering, and may be at a discount to the current market price of our common stock. Lock-Up Agreements Our directors, officers and certain stockholders have entered into lock-up agreements in connection with this offering. Under these agreements, these individuals have agreed, subject to specified exceptions, not to sell or transfer any shares of common stock or securities convertible into, or exchangeable or exercisable for, our common stock during a period ending ninety (90) days following the closing of this offering. Specifically, these individuals have agreed, in part, not to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise), or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, with respect to, any shares of our common stock or securities convertible